Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1988 1
1999 2
2005 1
2006 1
2008 2
2009 3
2010 3
2011 4
2012 3
2013 2
2014 1
2015 4
2016 3
2017 4
2018 1
2019 1
2020 2
2021 4
2023 1
2024 2
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Somatic mosaicism: on the road to cancer.
Fernández LC, Torres M, Real FX. Fernández LC, et al. Nat Rev Cancer. 2016 Jan;16(1):43-55. doi: 10.1038/nrc.2015.1. Epub 2015 Dec 18. Nat Rev Cancer. 2016. PMID: 26678315 Review.
Bi-modal strategy of gastrulation in reptiles.
Stower MJ, Diaz RE, Fernandez LC, Crother MW, Crother B, Marco A, Trainor PA, Srinivas S, Bertocchini F. Stower MJ, et al. Among authors: fernandez lc. Dev Dyn. 2015 Sep;244(9):1144-1157. doi: 10.1002/dvdy.24300. Epub 2015 Jul 14. Dev Dyn. 2015. PMID: 26088476 Free article.
Pharmacological inactivation of the prion protein by targeting a folding intermediate.
Spagnolli G, Massignan T, Astolfi A, Biggi S, Rigoli M, Brunelli P, Libergoli M, Ianeselli A, Orioli S, Boldrini A, Terruzzi L, Bonaldo V, Maietta G, Lorenzo NL, Fernandez LC, Codeseira YB, Tosatto L, Linsenmeier L, Vignoli B, Petris G, Gasparotto D, Pennuto M, Guella G, Canossa M, Altmeppen HC, Lolli G, Biressi S, Pastor MM, Requena JR, Mancini I, Barreca ML, Faccioli P, Biasini E. Spagnolli G, et al. Among authors: fernandez lc. Commun Biol. 2021 Jan 12;4(1):62. doi: 10.1038/s42003-020-01585-x. Commun Biol. 2021. PMID: 33437023 Free PMC article.
Somatic Embryonic FGFR2 Mutations in Keratinocytic Epidermal Nevi.
Toll A, Fernández LC, Pons T, Groesser L, Sagrera A, Carrillo-de Santa Pau E, Vicente A, Baselga E, Vázquez M, Beltrán S, Pisano DG, Rueda D, Gut M, Pujol RM, Hafner C, Gut I, Valencia A, Real FX. Toll A, et al. Among authors: fernandez lc. J Invest Dermatol. 2016 Aug;136(8):1718-1721. doi: 10.1016/j.jid.2016.03.040. Epub 2016 Apr 19. J Invest Dermatol. 2016. PMID: 27103312 Free article. No abstract available.
Mycobacterium chelonae infection associated with tattoos.
Rodríguez-Blanco I, Fernández LC, Suárez-Peñaranda JM, Pérez del Molino ML, Esteban J, Almagro M. Rodríguez-Blanco I, et al. Among authors: fernandez lc. Acta Derm Venereol. 2011 Jan;91(1):61-2. doi: 10.2340/00015555-1034. Acta Derm Venereol. 2011. PMID: 21264454 Free article. No abstract available.
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab.
Taylor KI, Lipsmeier F, Scelsi MA, Volkova-Volkmar E, Rukina D, Popp W, Lambrecht S, Anzures-Cabrera J, Summers D, Abt M, Monnet A, Kilchenmann T, Schjodt-Eriksen J, Essioux L, Kustermann T, Zago W, Svoboda H, Nikolcheva T, Postuma RB, Pagano G, Lindemann M; PASADENA Investigators; Prasinezumab Study Group. Taylor KI, et al. NPJ Digit Med. 2025 Jun 16;8(1):365. doi: 10.1038/s41746-025-01572-8. NPJ Digit Med. 2025. PMID: 40523921 Free PMC article.
Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson's disease trials.
Pagano G, Trundell D, Simuni T, Pavese N, Marek K, Postuma RB, Shariati N, Monnet A, Moore E, Davies EW, Svoboda H, Pross N, Bonni A, Nikolcheva T; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. NPJ Parkinsons Dis. 2025 Jul 1;11(1):193. doi: 10.1038/s41531-025-01041-9. NPJ Parkinsons Dis. 2025. PMID: 40593721 Free PMC article.
Bronchodilator responsiveness and future chronic airflow obstruction: a multinational longitudinal study.
Knox-Brown B, Algharbi F, Mulhern O, Potts J, Harrabi I, Janson C, Nielsen R, Agarwal D, Malinovschi A, Juvekar S, Denguezli M, Gíslason T, Ahmed R, Nafees A, Koul PA, Obaseki D, Anand MP, Loh LC, Dias HB, Rodrigues F, Mannino D, Elbiaze M, El Rhazi K, Mejza F, Devereux G, Franssen FME, El Sony A, Wouters E, Al Ghobain M, Mortimer K, Rashid A, Osman R, Studnicka M, Cardoso J, Burney P, Amaral AFS; BOLD Collaborative Research Group. Knox-Brown B, et al. EClinicalMedicine. 2025 Feb 21;81:103123. doi: 10.1016/j.eclinm.2025.103123. eCollection 2025 Mar. EClinicalMedicine. 2025. PMID: 40083442 Free PMC article.
COPD: Should Diagnosis Match Physiology?
Studnicka M, Horner A, Sator L, Buist AS, Lamprecht B; BOLD Collaborative Research Group. Studnicka M, et al. Chest. 2020 Feb;157(2):473-475. doi: 10.1016/j.chest.2019.09.039. Chest. 2020. PMID: 32033652 No abstract available.
45 results